2
Clinical Trials associated with GamFluVac(Gamaleya Research Institute Of Epidemiology And Microbiology)A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of Medicinal Product With a Period of Open Safety Assessment in Two Modes of Administration, in Healthy Volunteers
The aim of the present study is at the first stage: a comparative assessment of the safety of the two methods of vaccine administration, at the second - an assessment of the safety and state of post-vaccination immunity at different times after vaccination
An Open Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac Vector Vaccine Against Influenza A in Healthy Volunteers in 3 Groups With a Dose Escalation
The present clinical phase I study designed to examine the safety, reactogenicity and immunogenicity of the medicinal product - Vaccine vector against influenza A - in healthy volunteers after a single dose in the three groups with dose escalation.
100 Clinical Results associated with GamFluVac(Gamaleya Research Institute Of Epidemiology And Microbiology)
100 Translational Medicine associated with GamFluVac(Gamaleya Research Institute Of Epidemiology And Microbiology)
100 Patents (Medical) associated with GamFluVac(Gamaleya Research Institute Of Epidemiology And Microbiology)
100 Deals associated with GamFluVac(Gamaleya Research Institute Of Epidemiology And Microbiology)